Trump is correct. Too many drug prices are too high. How pharmacy benefit managers help inflate the prices of drugs in ...

Trump has threatened that pharmaceutical import tariffs could clock in at “25% or higher.” The President first floated the ...

There are fears surrounding one of Cork's most important industries as President Donald Trump has threatened a fresh round of ...

The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating ...

At the Heart in Diabetes CME Conference, speakers highlighted four recent reports published in the Journal of the American ...

Major global pharmaceutical companies traded lower in the premarket on Tuesday after President Donald Trump reiterated his ...

Pfizer’s stock slid a modest $0.20 to $24.34, despite option activity showing more bullish call buyers than sellers. Implied ...

Big Pharma executives have not been shy about their desire for deals, but companies have been battling macro headwinds ...

China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time ...

U.S. drugmakers are increasingly licensing drug candidates from Chinese biotech firms, with 14 such deals worth up to $18.3 ...

The PD-L1 Inhibitors drugs uptake section examines the rate at which newly launched or upcoming potential drugs are being ...

But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. The best way to find great value stocks is to pair a strong Zacks Rank with an ...